For the fourth quarter of 2011, Retalix Ltd - RTLX - posted total revenues of $62.5 million, a 16.2% increase year over year. GSE Systems Inc - GVP - announced new contracts valued at approximately $8.0 million involving nuclear, fossil, and process simulation, tutorials, and consulting services. Each of these projects was awarded during the first quarter of 2012. iBio Inc - IBIO - reported issuance of a US patent covering the use of iBio's proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications. ********************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

• Added by: karmastock
• Date added: 29/02/12
• Video Duration: 01:11
• Category: News
• Number of views:307
• Tags: Retalix, GSE Systems, iBio Inc, RTLX, GVP, IBIO, Amex:GVP, Amex:IBIO, Nasdaq:RTLX (RTLX, IBIO, GVP) CRWENewswire Stocks In Action



Post a Comment

To add a comment, please fill out the box below and click on the submit button. Comment:

There are currently no comments for this video